A5109739697- Cutaneous Melanoma Detection and Management
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Immunotherapy and Biomarkers
- Genetic factors in colorectal cancer
- Cardiac, Anesthesia and Surgical Outcomes
- Immunotherapy and Immune Responses
- AI in cancer detection
- Lung Cancer Research Studies
- Colorectal Cancer Surgical Treatments
- Aortic Disease and Treatment Approaches
- Melanoma and MAPK Pathways
- Colorectal Cancer Treatments and Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- CAR-T cell therapy research
- Digital Imaging for Blood Diseases
- Hepatitis B Virus Studies
- Aortic aneurysm repair treatments
- Esophageal and GI Pathology
- Cancer Genomics and Diagnostics
- Gastroesophageal reflux and treatments
- Gastric Cancer Management and Outcomes
University Hospitals of Cleveland
2024-2025
University School
2024
Case Western Reserve University
2024
Bharati Vidyapeeth Deemed University
2022
644 Background: There is limited data to guide surveillance in biliary tract cancers (BTCs) following resection. Minimal residual disease (MRD) assays utilize circulating tumor DNA (ctDNA) detect early recurrence. Current on the use of ctDNA conjunction with imaging. In this study, we aim elucidate role monitoring patients who have undergone curative Methods: We conducted a retrospective search at tertiary care and several satellite settings identify BTCs underwent surgery subsequently had...
639 Background: Limited treatment options exist for patients with locally advanced or metastatic biliary tract cancers (BTCs). Recently, several clinical trials provided preliminary evidence human epidermal growth factor receptor-2 (HER2) as a new target HER2 expressing BTC. We conducted systematic review and pooled analysis of the safety efficacy anti-HER2 agents in Methods: A comprehensive search PubMed/MEDLINE EMBASE was performed to identify phase 1, 2, 3 published between January 2019...
The combination of capecitabine and oxaliplatin (CAPOX) is commonly used in patients with localized colorectal cancer (CRC) receiving curative-intent treatment. Our study aimed to assess the real-world tolerability CAPOX a single-institution cohort CRC. This retrospective that included CRC neoadjuvant or adjuvant CAPOX. primary end point was completion rate intended number (obtained by chart review) cycles irrespective dose levels. Secondary outcome measures grade ≥3 adverse events, hospital...
Melanoma, a deadly skin cancer, is caused due to the development of malignant tumor melanocytes. Melanoma most harmful form carcinoma, by pigment-making cells, called responsible for 75 percent cancer deaths. The survival rate patients over past five years' analysis shows that only 15% patients' has been chronically treated. problem lies in manual system. There are about six maximum colors mole, so problematic thing image, there several shades and it difficult recognize human beings. So we...
Introduction: In 2011, immunotherapy and targeted therapy revolutionized melanoma treatment. However, inequities in their use may limit the benefits seen by certain patients. Methods: We performed a retrospective review of patients National Cancer Database for with stage IV from 2 time periods: 2004–2010 2016–2020, distinguishing between those who received systemic did not. investigated rates factors associated treatment omission. employed Kaplan-Meier analysis to explore impact on overall...
Melanoma survival has greatly improved with the advent of immunotherapy, but unequal access to these medications may exist due nonmedical patient factors such as insurance status, educational background, and geographic proximity treatment.